Production facilities
/userfiles/images/api/pati/6.jpg)
Our processes are fully and vertically integrated from research and development to the pilot plant to scaling up to commercial manufacturing. API manufacturing is carried out in cGMP-compliant and FDA-approved multipurpose plants.
Latest news
Successful GMP audit by Japanese companies
Thursday, 01-07-2010
Polpharma Fine Chemicals Business Unit passed successfully inspection by two of the major generic Japanese...
EU DMF for Solifenacin succinate available
Wednesday, 12-05-2010
EU DMF documentation in eCTD format for Solifenacin succinate manufactured by Polpharma Fine Chemicals...
Polpharma recognised for investing in research and development
Tuesday, 04-05-2010
Polpharma reached the top leaders of the ranking of the largest investors in research and development in...
Process Excellence Award
Wednesday, 28-04-2010
Polpharma was ranked among the first three companies in the “Green Process Award”, of the 11th...